iRadimed
IRMD
59 hedge funds and large institutions have $63.7M invested in iRadimed in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 7 closing their positions.
178% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 9
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
16% more capital invested
Capital invested by funds: $54.7M → $63.7M (+$8.95M)
9% more funds holding
Funds holding: 54 → 59 (+5)
2.66% more ownership
Funds ownership: 23.99% → 26.65% (+2.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.46M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$1.46M |
| 3 |
RC
Roubaix Capital
Denver,
Colorado
|
+$1.34M |
| 4 |
Renaissance Technologies
New York
|
+$1.1M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NA
Navellier & Associates
Reno,
Nevada
|
-$2.11M |
| 2 |
CI
Cavalier Investments
Alpharetta,
Georgia
|
-$987K |
| 3 |
SIM
Spark Investment Management
New York
|
-$516K |
| 4 |
LPL Financial
San Diego,
California
|
-$441K |
| 5 |
Two Sigma Advisers
New York
|
-$252K |
IRMD Hedge Fund Activity: Q3 2019 in Review
59 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2019, worth a combined $63.7M — up 16% from $54.7M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new IRMD positions and 7 closed out — a net gain of 5 holders — while 25 added to existing stakes and 9 trimmed.
The largest buyer was Nuveen, opening a new position worth an estimated $1.46M. The largest seller was Navellier & Associates, cutting an estimated $2.11M.
- 59 institutional investors held iRadimed (IRMD) as of Q3 2019, up from 54 in Q2 2019.
- Funds reported $63.7M of iRadimed stock for Q3 2019, up 16% quarter-over-quarter.
- 12 funds opened new iRadimed positions in Q3 2019 and 7 closed out, a net change of +5 holders.
- The largest iRadimed buyer in Q3 2019 was Nuveen, an estimated $1.46M added.
- The largest iRadimed seller in Q3 2019 was Navellier & Associates, an estimated $2.11M sold.
Based on aggregated 13F filings for Q3 2019.